Viseven’s , eWizard platform has introduced eVa, a specialized AI agent designed to transform content creation for marketing and medical teams in the pharmaceutical and life sciences sectors. Launched on June 15, 2025, eVa automates workflows, accelerates Medical-Legal-Review (MLR) processes, and ensures compliance, addressing key industry challenges.
eVa is an AI agent for pharma content creation by eWizard.
Automates workflows, reducing MLR review time significantly.
Integrates with DAM systems for brand-approved assets.
Generates layouts, copy, and visuals in minutes.
Flags compliance issues before content approval.
Builds on eWizard’s 2025 Gold Globee® Award-winning platform.
eVa simplifies the fragmented process of creating pharmaceutical content, eliminating the need to juggle multiple tools. From rep-triggered emails to comprehensive eDetailer decks, eVa generates complete content layouts in minutes, including on-brand copy, visuals, and structure. By connecting to digital asset management (DAM) systems, it pulls approved text and suggests relevant images, ensuring brand consistency.
Compliance is critical in life sciences, and eVa embeds it into the workflow. The AI flags potential compliance issues and suggests corrections before content reaches the MLR stage, reducing review cycles. When generating new copy or visuals, eVa labels them as “AI-generated” for transparency. Dan Atieh, Head of Product, eWizard, stated: "We built eVa not just to speed up content creation, but to build trust in the process. Compliance is a conversation, not a checkbox — and eVa brings that conversation into the heart of the workflow."
eVa integrates with existing eWizard platforms, allowing teams to work within familiar systems. It leverages brand-approved assets for consistency and simplifies localization, adapting content efficiently for different markets. This ensures faster campaign launches while maintaining compliance and message integrity, addressing the industry’s need for speed without sacrificing quality.
eVa builds on eWizard’s proven success, recognized as a Gold Globee® Award Winner for Most Innovative Product of the Year in June 2025. The platform’s ability to reduce manual tasks, accelerate MLR reviews, and enable omnichannel orchestration underpins eVa’s value. Dan Atieh reiterated: "We built eVa not just to speed up content creation, but to build trust in the process. Compliance is a conversation, not a checkbox — and eVa brings that conversation into the heart of the workflow."
eVa by eWizard represents a leap forward for pharmaceutical content creation, offering an all-in-one AI solution that balances speed, compliance, and quality. It empowers teams to deliver impactful campaigns efficiently, reinforcing eWizard’s leadership in life sciences innovation.
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones—and thrive on the tech pulse.